Pfizer boosts profit estimate, even as tariffs are absorbed and drug prices may be cut

Pfizer’s stock gains after the drugmaker boosted its full-year profit outlook.

Previous Article

Molson Coors cuts earnings outlook because of aluminum tariffs and a slowing economy

Next Article

Chelsea Handler talks about her boozy lemonade, the meaning of turning 50 and why real-estate is the best investment

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

+ 87 = 93
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨